Skip to content

Bribery/Anti-corruption: Novartis (via The Lawyer)

March 21, 2011

Thomas Werlen at The Lawyer comments on the $422 million fine against pharmaceutical giant Novartis for off-label marketing of the epilepsy drug, Trileptal.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: